Onasemnogene Abeparvovec: First Global Approval.
- Published in:
- Drugs, 2019, v. 79, n. 11, p. 1255, doi. 10.1007/s40265-019-01162-5
- By:
- Publication type:
- Article
Works matching IS 00126667 AND DT 2019 AND VI 79 AND IP 11
Results: 9
1
2
Alpelisib: First Global Approval.
- Published in:
- Drugs, 2019, v. 79, n. 11, p. 1249, doi. 10.1007/s40265-019-01161-6
- By:
- Publication type:
- Article
3
Naldemedine: A Review in Opioid-Induced Constipation.
- Published in:
- Drugs, 2019, v. 79, n. 11, p. 1241, doi. 10.1007/s40265-019-01160-7
- By:
- Publication type:
- Article
4
Pharmaceutical Management of Ovarian Cancer: Current Status.
- Published in:
- Drugs, 2019, v. 79, n. 11, p. 1231, doi. 10.1007/s40265-019-01158-1
- By:
- Publication type:
- Article
5
Perioperative Pain Management in Morbid Obesity.
- Published in:
- Drugs, 2019, v. 79, n. 11, p. 1163, doi. 10.1007/s40265-019-01156-3
- By:
- Publication type:
- Article
6
Advances in Targeted Therapies for Triple-Negative Breast Cancer.
- Published in:
- Drugs, 2019, v. 79, n. 11, p. 1217, doi. 10.1007/s40265-019-01155-4
- By:
- Publication type:
- Article
7
Designing Poly-agonists for Treatment of Metabolic Diseases: Challenges and Opportunities.
- Published in:
- Drugs, 2019, v. 79, n. 11, p. 1187, doi. 10.1007/s40265-019-01153-6
- By:
- Publication type:
- Article
8
Current Concepts and Future Approaches in the Treatment of Cutaneous Lupus Erythematosus: A Comprehensive Review.
- Published in:
- Drugs, 2019, v. 79, n. 11, p. 1199, doi. 10.1007/s40265-019-01151-8
- By:
- Publication type:
- Article
9
From DNA Sequencing to Clinical Trials: Finding New Targeted Drugs for Acute Myeloid Leukemia.
- Published in:
- Drugs, 2019, v. 79, n. 11, p. 1177, doi. 10.1007/s40265-019-01144-7
- By:
- Publication type:
- Article